Literature DB >> 26948349

Histologic classification of gliomas.

Arie Perry1, Pieter Wesseling2.   

Abstract

Gliomas form a heterogeneous group of tumors of the central nervous system (CNS) and are traditionally classified based on histologic type and malignancy grade. Most gliomas, the diffuse gliomas, show extensive infiltration in the CNS parenchyma. Diffuse gliomas can be further typed as astrocytic, oligodendroglial, or rare mixed oligodendroglial-astrocytic of World Health Organization (WHO) grade II (low grade), III (anaplastic), or IV (glioblastoma). Other gliomas generally have a more circumscribed growth pattern, with pilocytic astrocytomas (WHO grade I) and ependymal tumors (WHO grade I, II, or III) as the most frequent representatives. This chapter provides an overview of the histology of all glial neoplasms listed in the WHO 2016 classification, including the less frequent "nondiffuse" gliomas and mixed neuronal-glial tumors. For multiple decades the histologic diagnosis of these tumors formed a useful basis for assessment of prognosis and therapeutic management. However, it is now fully clear that information on the molecular underpinnings often allows for a more robust classification of (glial) neoplasms. Indeed, in the WHO 2016 classification, histologic and molecular findings are integrated in the definition of several gliomas. As such, this chapter and Chapter 6 are highly interrelated and neither should be considered in isolation.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  astrocytoma; ependymoma; glioblastoma; glioma; glioneuronal tumor; histopathology; immunohistochemistry; molecular diagnostics; neuropathology; oligodendroglioma

Mesh:

Year:  2016        PMID: 26948349     DOI: 10.1016/B978-0-12-802997-8.00005-0

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  73 in total

1.  Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study.

Authors:  M D Maldonado; P Batchala; D Ornan; C Fadul; D Schiff; J N Itri; R Jain; S H Patel
Journal:  J Neurooncol       Date:  2018-06-29       Impact factor: 4.130

2.  Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

Authors:  Gary Kohanbash; Diego A Carrera; Shruti Shrivastav; Brian J Ahn; Naznin Jahan; Tali Mazor; Zinal S Chheda; Kira M Downey; Payal B Watchmaker; Casey Beppler; Rolf Warta; Nduka A Amankulor; Christel Herold-Mende; Joseph F Costello; Hideho Okada
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

3.  Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial.

Authors:  Hamed Arami; Chirag B Patel; Steven J Madsen; Peter J Dickinson; Ryan M Davis; Yitian Zeng; Beverly K Sturges; Kevin D Woolard; Frezghi G Habte; Demir Akin; Robert Sinclair; Sanjiv S Gambhir
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

4.  Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin.

Authors:  Sophie A Dusoswa; Jan Verhoeff; Erik Abels; Santiago P Méndez-Huergo; Diego O Croci; Lisan H Kuijper; Elena de Miguel; Valerie M C J Wouters; Myron G Best; Ernesto Rodriguez; Lenneke A M Cornelissen; Sandra J van Vliet; Pieter Wesseling; Xandra O Breakefield; David P Noske; Thomas Würdinger; Marike L D Broekman; Gabriel A Rabinovich; Yvette van Kooyk; Juan J Garcia-Vallejo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

5.  Homeobox B8 Targets Sterile Alpha Motif Domain-Containing Protein 9 and Drives Glioma Progression.

Authors:  Wenping Ma; Hongze Jin; Wenjie Liu; Xiaojuan Li; Xingang Zhou; Xinwu Guo; Runfa Tian; Qi Cui; Junjie Luo; Yueying Jiao; Youtao Yu; Haifeng Yang; Hongshan Zhao
Journal:  Neurosci Bull       Date:  2019-10-23       Impact factor: 5.203

Review 6.  The Effect of Molecular Diagnostics on the Treatment of Glioma.

Authors:  Nancy Ann Oberheim Bush; Nicholas Butowski
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

Review 7.  Characterization of gliomas: from morphology to molecules.

Authors:  Sean P Ferris; Jeffrey W Hofmann; David A Solomon; Arie Perry
Journal:  Virchows Arch       Date:  2017-07-04       Impact factor: 4.064

8.  Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth.

Authors:  Daniela Vasconcelos Lopes; Amanda de Fraga Dias; Luiz Fernando Lopes Silva; Juliete Nathali Scholl; Jean Sévigny; Ana Maria Oliveira Battastini; Fabrício Figueiró
Journal:  Purinergic Signal       Date:  2021-03-20       Impact factor: 3.765

9.  SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu.

Authors:  Kehua Pan; Xince Huang; Xiufen Jia
Journal:  Oncol Lett       Date:  2021-04-21       Impact factor: 2.967

10.  Altered Expression of miR-575 in Glioma is Related to Tumor Cell Proliferation, Migration, and Invasion.

Authors:  Guangxin Wei; Shengjun Li; Pengcheng Wang; Shouxian Wang; Yujing Zhao
Journal:  Neuromolecular Med       Date:  2021-07-16       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.